Literature DB >> 19457996

Regulation of the ORF61 promoter and ORF61 functions in varicella-zoster virus replication and pathogenesis.

Li Wang1, Marvin Sommer, Jaya Rajamani, Ann M Arvin.   

Abstract

Varicella-zoster virus (VZV) open reading frame 61 (ORF61) encodes a protein that transactivates viral and cellular promoters in transient-transfection assays and is the ortholog of herpes simplex virus ICP0. In this report, we mapped the ORF61 promoter and investigated its regulation by viral and cellular proteins in transient-expression experiments and by mutagenesis of the VZV genome (parent Oka strain). The 5' boundary of the minimal ORF61 promoter required for IE62 transactivation was mapped to position -95 relative to the mRNA start site, and three noncanonical GT-rich Sp1-binding sites were documented to occur within the region comprising positions -95 to -45. Contributions of the three Sp1-binding-site motifs, designated Sp1a, Sp1b, and Sp1c, to ORF61 expression and viral replication were varied despite their similar sequences. Two sites, Sp1a and Sp1c, functioned synergistically. When both sites were mutated in the pOka genome to produce pOka-61proDeltaSp1ac, the mutant virus expressed significantly less ORF61 protein. Using this mutant to investigate ORF61 functions resulted in reductions in the expression levels of IE proteins, viral kinases ORF47 and ORF66, and the major glycoprotein gE, with the most impact on gE. Virion morphogenesis appeared to be intact despite minimal ORF61 expression. Pretreating melanoma cells with sodium butyrate enhanced titers of pOka-61proDeltaSp1ac but not pOka, suggesting that ORF61 has a role in histone deacetylase inhibition. Growth of pOka-61proDeltaSp1ac was impaired in SCIDhu skin xenografts, indicating that the regulation of the ORF61 promoter by Sp1 family proteins is important for ORF61 expression in vivo and that ORF61 contributes to VZV virulence at skin sites of replication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457996      PMCID: PMC2708633          DOI: 10.1128/JVI.00118-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  84 in total

1.  Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model.

Authors:  Takahiro Niizuma; Leigh Zerboni; Marvin H Sommer; Hideki Ito; Stewart Hinchliffe; Ann M Arvin
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 2.  Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1.

Authors:  Ryan Hagglund; Bernard Roizman
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

3.  The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter.

Authors:  W S Dynan; R Tjian
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

4.  Evidence for a direct role for both the 175,000- and 110,000-molecular-weight immediate-early proteins of herpes simplex virus in the transactivation of delayed-early promoters.

Authors:  P O'Hare; G S Hayward
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

5.  Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1.

Authors:  Patrick Lomonte; Joëlle Thomas; Pascale Texier; Cécile Caron; Saadi Khochbin; Alberto L Epstein
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Interaction between the varicella zoster virus IE62 major transactivator and cellular transcription factor Sp1.

Authors:  Hua Peng; Hongying He; John Hay; William T Ruyechan
Journal:  J Biol Chem       Date:  2003-07-10       Impact factor: 5.157

7.  The herpes simplex virus type 1 (HSV-1) regulatory protein ICP0 interacts with and Ubiquitinates p53.

Authors:  Chris Boutell; Roger D Everett
Journal:  J Biol Chem       Date:  2003-07-09       Impact factor: 5.157

8.  Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene.

Authors:  I H Gelman; S Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

9.  Herpes simplex virus 1 mutant in which the ICP0 HUL-1 E3 ubiquitin ligase site is disrupted stabilizes cdc34 but degrades D-type cyclins and exhibits diminished neurotoxicity.

Authors:  Ryan Hagglund; Bernard Roizman
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity.

Authors:  R D Everett
Journal:  EMBO J       Date:  1984-12-20       Impact factor: 11.598

View more
  20 in total

1.  Identification and functional characterization of the Varicella zoster virus ORF11 gene product.

Authors:  Xibing Che; Stefan L Oliver; Marvin H Sommer; Jaya Rajamani; Mike Reichelt; Ann M Arvin
Journal:  Virology       Date:  2011-01-26       Impact factor: 3.616

Review 2.  Molecular mechanisms of varicella zoster virus pathogenesis.

Authors:  Leigh Zerboni; Nandini Sen; Stefan L Oliver; Ann M Arvin
Journal:  Nat Rev Microbiol       Date:  2014-02-10       Impact factor: 60.633

3.  Cellular transcription factor YY1 mediates the varicella-zoster virus (VZV) IE62 transcriptional activation.

Authors:  Mohamed I Khalil; Marvin Sommer; Ann Arvin; John Hay; William T Ruyechan
Journal:  Virology       Date:  2013-12-12       Impact factor: 3.616

4.  Dysregulated Glycoprotein B-Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription during Infection.

Authors:  Stefan L Oliver; Edward Yang; Ann M Arvin
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

5.  The RING finger domain of Varicella-Zoster virus ORF61p has E3 ubiquitin ligase activity that is essential for efficient autoubiquitination and dispersion of Sp100-containing nuclear bodies.

Authors:  Matthew S Walters; Christos A Kyratsous; Saul J Silverstein
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

Review 6.  VZV infection of keratinocytes: production of cell-free infectious virions in vivo.

Authors:  Michael D Gershon; Anne A Gershon
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

7.  Attenuation of the adaptive immune response in rhesus macaques infected with simian varicella virus lacking open reading frame 61.

Authors:  Christine Meyer; Amelia Kerns; Kristen Haberthur; Jesse Dewane; Joshua Walker; Wayne Gray; Ilhem Messaoudi
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

8.  Regulation of the varicella-zoster virus ORF3 promoter by cellular and viral factors.

Authors:  Mohamed I Khalil; Marvin Sommer; Ann Arvin; John Hay; William T Ruyechan
Journal:  Virology       Date:  2013-03-21       Impact factor: 3.616

9.  Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor.

Authors:  Zhen Zhang; Anca Selariu; Charles Warden; Grace Huang; Ying Huang; Oluleke Zaccheus; Tong Cheng; Ningshao Xia; Hua Zhu
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

10.  Identification of a hydrophobic domain in varicella-zoster virus ORF61 necessary for ORF61 self-interaction, viral replication, and skin pathogenesis.

Authors:  Li Wang; Jaya Rajamani; Marvin Sommer; Leigh Zerboni; Ann M Arvin
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.